Loading...
XJPX
3401
Market cap2.00bUSD
Jul 10, Last price  
1,662.50JPY
1D
-1.13%
1Q
-2.98%
Jan 2017
-29.82%
Name

Teijin Ltd

Chart & Performance

D1W1MN
XJPX:3401 chart
P/E
P/S
0.37
EPS
Div Yield, %
2.97%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
0.86%
Revenues
873.19b
-13.16%
1,009,586,000,0001,036,623,000,000943,409,000,000765,840,000,000815,655,000,000854,370,000,000745,712,000,000784,424,000,000786,171,000,000790,748,000,000741,291,000,000834,986,000,000888,589,000,000853,746,000,000836,512,000,000926,054,000,0001,018,751,000,000960,459,000,0001,005,471,000,000873,190,000,000
Net income
-88.00b
L
34,124,000,00012,612,000,000-42,963,000,000-35,683,000,00025,182,000,00011,979,000,000-29,130,000,0008,356,000,000-8,086,000,00031,090,000,00050,133,000,00045,556,000,00045,057,000,00025,253,000,000-6,661,000,00023,158,000,000-17,695,000,000-11,712,000,00028,348,000,000-88,004,000,000
CFO
98.65b
+41.25%
96,455,000,00053,739,000,00040,391,000,00080,432,000,00077,132,000,00053,668,000,00064,305,000,00038,586,000,00076,030,000,00080,640,000,00079,040,000,00080,092,000,00080,899,000,00094,214,000,000107,729,000,00089,656,000,00055,086,000,00080,595,000,00069,843,000,00098,654,000,000
Dividend
Sep 29, 202625 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, operates across multiple key sectors including fibers, films, composites, healthcare, and IT. The company's advanced materials portfolio encompasses various fibers such as aramid, carbon, and polyester, alongside specialized films like polycarbonate and high-density polyethylene. It also produces resins, molded parts, and additives, as well as lightweight glass and carbon fiber reinforced composites, particularly for automotive applications. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint, respiratory, and cardiovascular diseases. It further provides medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders, complemented by orthopedic implants and functional food ingredients. Beyond materials and healthcare, Teijin offers IT solutions like Recopic, an RFID technology for inventory management. The company also leverages its engineering expertise to address global issues such as environmental pollution, energy supply stability, and challenges associated with an aging workforce population.
IPO date
May 16, 1949
Employees
22,484
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT